Gian Life Care Ltd.

View in App
19.70 +0.52 ▲2.7%

07 December 2023, 03:31:00 PM
Volume: 59,058

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.gianpathlabs.com
Market Cap 20.27 Cr.
Enterprise Value(EV) 21.23 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.34 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 14.68 Trailing Twelve Months Ending 2023-09
Industry PE 63.11 Trailing Twelve Months Ending 2023-09
Book Value / Share 15.07 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.30 Calculated using Price: 19.60
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.03 Cr. 10,341,527 Shares
FaceValue 10
About Gian Life Care Ltd.
The company is engaged in the business of providing diagnostic and related healthcare services. The company provides a wide range of diagnostic tests and services like patient diagnosis services, prevention, and wellness diagnosis services to patients and healthcare providers. The company caters to individual patients, hospitals, corporates and other healthcare providers. The company offers various tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, and radiology services.

Gian Life Care Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Gian Life Care Ltd. Performance

View details >>
1 Day
+2.71%
1 Week
+1.70%
1 Month
-2.43%
3 Month
-24.69%
6 Month
-8.84%
1 Year
-13.22%
2 Year
-51.33%
5 Year
10 Year

Gian Life Care Ltd. Fundamental Ratios

View details >>
1 years 2022-03
Return on Equity (%) 31.16
Return on Capital Employed (%) 44.24
Return on Assets (%) 18.95

Gian Life Care Ltd. Balance Sheet

View details >>
Particulars 3 years 2022-03 Rs. Cr. 2023-03* Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 14 15 16
Non Curr. Liab. 2 2 2
Curr. Liab. 7 11 13
Minority Int.
Equity & Liab. 23 28 30
Non Curr. Assets 13 17 18
Curr. Assets 10 11 12
Misc. Exp. not W/O
Total Assets 23 28 30

Gian Life Care Ltd. Profit and Loss

View details >>
Particulars 2 years 2022-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 16 11
Other Income 1 1
Total Income 16 12
Total Expenditure -9 -9
PBIDT 7 3
Interest -1 0
Depreciation 0 -1
Taxation -1 -1
Exceptional Items
PAT 4 1
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 4 1
Adjusted EPS 4 1

Gian Life Care Ltd. Cash Flow

View details >>
Particulars 1 years 2022-03 Rs. Cr.
Cash Fr. Operatn. 6
Cash Fr. Inv. -4
Cash Fr. Finan. 1
Net Change 2
Cash & Cash Eqvt 5

Gian Life Care Ltd. Shareholding Pattern

View details >>
9 Qtrs 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 69.87 69.87 69.87 64.95 60.77 60.68 56.90 53.10 53.10
Public 30.13 30.13 30.13 35.05 39.23 39.32 43.10 46.90 46.90
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Gian Life Care Ltd. Announcements

View details >>
Tue, 14 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Publications
Sat, 11 Nov 2023
Results For The Period Ended September 30 2023
Dear Sir/ Maam

Please find attached herewith Unaudited Standalone and Consolidated Financial Results for the quarter/ half year ended September 30 2023.

For Gian Life Care Limited
Sat, 11 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday November 11 2023
Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today i.e. November 11 2023 has inter-alia considered and approved the following:-1. Unaudited Standalone and Consolidated Financial results of the Company for the quarter/ half year ended 30th September 2023. (Copy enclosed along with Limited Review Report). The Board Meeting commenced at 02:30 P.M and concluded at 03.30 P.M.You are requested to kindly take the above information in your records.Thanking You Yours faithfully For GIAN LIFE CARE LIMITED

Gian Life Care Ltd. Technical Scans

View details >>
Wed, 06 Dec 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months

Gian Life Care Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,505.54 1,239.30 -0.1%
Divi's Laboratories Ltd. 99,176.41 3,734.35 0.0%
Cipla Ltd. 97,326.09 1,222.80 +1.5%
Dr. Reddy's Laboratories Ltd. 95,542.33 5,785.10 +1.0%
Apollo Hospitals Enterprise Ltd. 79,692.65 5,461.40 -1.5%
Mankind Pharma Ltd. 78,212.89 1,992.25 +2.2%
Torrent Pharmaceuticals Ltd. 70,379.73 2,100.55 +1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.80 1,239.30 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 74.47 3,734.35 0.0%
Cipla Ltd. Consolidated 2023-09 28.18 1,222.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.77 5,785.10 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.26 5,461.40 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.02 1,992.25 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.76 2,100.55 +1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,239.30 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 7.82 3,734.35 0.0%
Cipla Ltd. Consolidated 2023-09 3.92 1,222.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.75 5,785.10 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.26 5,461.40 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,992.25 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.49 2,100.55 +1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,239.30 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,734.35 0.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,222.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,785.10 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,461.40 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,992.25 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,100.55 +1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,239.30 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,734.35 0.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,222.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,785.10 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,461.40 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,992.25 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,100.55 +1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,239.30 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,734.35 0.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,222.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,785.10 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,461.40 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,992.25 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,100.55 +1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,239.30 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,734.35 0.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,222.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,785.10 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,461.40 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,992.25 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,100.55 +1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,239.30 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,734.35 0.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,222.80 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,785.10 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,461.40 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,992.25 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,100.55 +1.0%

Gian Life Care Ltd. FAQ's

What is Gian Life Care share price?
Can I buy Gian Life Care shares now?
What is the Market Cap of Gian Life Care?
What are the key metrics to analyse Gian Life Care?
What is the 52 Week High and Low of Gian Life Care?
What is the trend of Gian Life Care share price?